Patents Assigned to VYRIPHARM LLC
  • Patent number: 10222361
    Abstract: Embodiments of the invention include integrated systems and methods of evaluating cannabis and cannabinoid products for public safety, quality control and quality assurance purposes for research and public use purposes. Embodiments of the invention facilitate suppliers and consumers of a cannabis and/or cannabinoid product to evaluate the origin, efficacy, potency, and quality of the product. Embodiments of the invention also include cannabis processing center where samples of the products are analyzed for research studies to test and set parameters for third parties. Embodiments of the invention include, for example, analyzing cannabis products to determine quality and quantity of desired components and undesired components, determining concentrations of cannabinoids in the product, and comparing measures of components in the product against regulations.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: March 5, 2019
    Assignee: VYRIPHARM LLC
    Inventors: Elias Bernard Jackson, Jr., Jerry L. Bryant, Jr.
  • Patent number: 9632069
    Abstract: Embodiments of the invention include integrated systems and methods of evaluating cannabis and cannabinoid products for public safety, quality control and quality assurance purposes for research and public use purposes. Embodiments of the invention facilitate suppliers and consumers of a cannabis and/or cannabinoid product to evaluate the origin, efficacy, potency, and quality of the product. Embodiments of the invention also include cannabis processing center where samples of the products are analyzed for research studies to test and set parameters for third parties. Embodiments of the invention include, for example, analyzing cannabis products to determine quality and quantity of desired components and undesired components, determining concentrations of cannabinoids in the product, and comparing measures of components in the product against regulations.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: April 25, 2017
    Assignee: VYRIPHARM LLC
    Inventors: Elias Bernard Jackson, Jr., Jerry L. Bryant, Jr.